Vivianne Velez-Bravo

Epidemiology of myelodysplastic syndromes.

E. Estey, S. Strom, Vivianne Velez-Bravo, 2008, Seminars in hematology.

SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.

G. Mills, E. Winer, K. Do, 2015, Journal of the National Cancer Institute.

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

Y. Oki, F. Meric-Bernstam, R. Kurzrock, 2020, Clinical Cancer Research.

Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy

F. Meric-Bernstam, R. Kurzrock, F. Janku, 2016, Oncotarget.

Abstract LB-231: Phase Ib dose escalation and biomarker study of MK2206 in combination with standard doses of weekly paclitaxel in patients with locally advanced or metastatic solid tumors with expansion in advanced breast cancer

G. Mills, F. Meric-Bernstam, R. Kurzrock, 2012 .

Phase I Trial of Dabrafenib and Pazopanib in BRAF Mutated Advanced Malignancies.

Vanda M. Stepanek, F. Janku, L. Schaaf, 2018, JCO precision oncology.